ResearchClinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified Sarcomas
ResearchPatterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency
ResearchSupporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates
ResearchEffect of HLA Restriction on Racial and Ethnic Disparities in Access to Immune Therapies for Advanced Synovial Sarcoma
ResearchDisrupted Independence-Supporting Adolescents and Young Adults with Sarcoma in Maintaining Autonomy: A Qualitative Study
ResearchSafety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
ResearchClosing the Gap: Proposing a Socio-ecological Framework to Make Cancer Clinical Trials More Accessible, Equitable, and Acceptable to Adolescents and Young Adults
ResearchIncidence of Bleeding Events in Patients on Concomitant Tyrosine Kinase Inhibitors and Selective Serotonin Reuptake Inhibitors
ResearchArsenic Toxicity Manifesting as Profuse Watery Diarrhea During Induction Therapy for Acute Promyelocytic Leukemia
ResearchSecondary Histiocytic Sarcoma with BRAF Mutation Responsive to MAPK-targeted Therapy Presenting with Recurrence with mTOR Mutation Responsive to mTOR-targeted Therapy